{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:07Z","timestamp":1791300487790,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.semarthrit.2011.09.008","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T13:27:17Z","timestamp":1320931637000},"page":"890-899","source":"Crossref","is-referenced-by-count":203,"title":["Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody"],"prefix":"10.1016","volume":"41","author":[{"given":"Isabelle","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Yves","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dominique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cherin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2011.09.008_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2474-11-223","article-title":"Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis","volume":"11","author":"Kang","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","article-title":"Diagnostic utility of anti-Ro52 detection in systemic autoimmunity","volume":"86","author":"Dugar","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib10","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"V\u00e1ncsa","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: first of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: second of two parts","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Suppl 5","key":"10.1016\/j.semarthrit.2011.09.008_bib17","first-page":"1","article-title":"Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.210.2.r99ja15333","article-title":"Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients","volume":"210","author":"Akira","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","article-title":"High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis","volume":"11","author":"Ikezoe","year":"1996","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/art.30513","article-title":"Short term and long term outcome of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/ajr.169.1.9207505","article-title":"Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT","volume":"169","author":"Mino","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1440-1843.2009.01626.x","article-title":"Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis?","volume":"14","author":"Schmidt","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2483071378","article-title":"Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study","volume":"249","author":"Shin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib25","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.21.4.360","article-title":"Precipitating autoantibodies in the connective tissue diseases","volume":"21","author":"Anderson","year":"1962","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib28","first-page":"183","article-title":"The mapping of the human 52-kD Ro\/SSA autoantigen gene to human chromosome 11, and its polymorphisms","volume":"52","author":"Frank","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib29","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","article-title":"A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle","volume":"167","author":"Ben-Chetrit","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib30","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib31","first-page":"681","article-title":"Periarticular calcifications and arthropathy as the first manifestation of polymyositis","volume":"21","author":"Marie","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.1780190217","article-title":"Deforming arthritis of the hands in polymyositis","volume":"19","author":"Bunch","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib33","first-page":"551","article-title":"Apatite deposition in polymyositis subluxing arthropathy","volume":"23","author":"Citera","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib34","first-page":"605","article-title":"Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody","volume":"14","author":"Cohen","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib35","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/art.1780331106","article-title":"A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis\/dermatomyositis","volume":"33","author":"Oddis","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib36","first-page":"1401","article-title":"Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis","volume":"28","author":"Queiro-Silva","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","article-title":"Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies","volume":"39","author":"Yoshifuji","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib40","first-page":"169","article-title":"Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome","volume":"35","author":"Legault","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the anti-synthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/rheumatology\/keg473","article-title":"Jo-1 syndrome with associated poorly differentiated adenocarcinoma","volume":"43","author":"Watkins","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2011.09.008_bib44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J Exp Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T12:57:05Z","timestamp":1543409825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017211002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0049017211002800"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.09.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}